Skip to main content
. 2013 Oct 8;18(10):12368–12395. doi: 10.3390/molecules181012368

Figure 3.

Figure 3

Schematic representation of the dual mechanism of action of telomeric G4 ligands. Possible resistance mechanisms that enable tumor cells to cope with telomeric G4-ligand-mediated detrimental effects have been also reported.